Multi-Center Clean Air Randomized Controlled Trial in COPD
Start Date
5/24/2024
Completion Date
8/31/2029
Summary
This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air quality on reducing COPD exacerbation risk and improving quality of life, functional status, rescue medication use.
Detailed Description
The Multi-Center Clean Air Randomized Controlled Trial in COPD (Clean Air) is a multi-center, prospective, randomized, double-blind, sham-controlled trial that will enroll 770 former smokers with COPD over a 4-year period and follow participants at regular intervals for one year. The primary endpoint is respiratory specific quality of life. Secondary endpoints include rate of acute exacerbations, rescue medication use, quality of life, and cost-effectiveness.
Eligibility Criteria
Age Range: 40 years to No maximum
Interventions
Air cleaner
Sham air cleaner
Conditions
Locations
University of Alabama, Lung Health Center
Birmingham, Alabama 35233
United States
University of California, Los Angeles
Los Angeles, California 90095
United States
University of Iowa
Iowa City, Iowa 52242
United States
University of Maryland
Baltimore, Maryland 21201
United States
Johns Hopkins
Baltimore, Maryland 21224
United States
Tidal Health
Salisbury, Maryland 21801
United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215
United States
University of Michigan
Ann Arbor, Michigan 48109
United States
Dartmouth Hitchcock
Lebanon, New Hampshire 03756
United States
Cleveland Clinic
Cleveland, Ohio 44195
United States
Reading Hospital
West Reading, Pennsylvania 19611
United States